Pulmonx
Christina M. has over 15 years of experience in reimbursement and patient access roles within the healthcare sector. Currently serving as Reimbursement Support at Pulmonx Corporation since April 2023, Christina previously worked at Nevro as a Patient Access Specialist from July 2017 to April 2023. Additional experience includes patient access and site coordination roles at Compass Consulting and Lash Group, along with positions as a Case Manager and Reimbursement Counselor at various pharmaceutical companies. Christina began their career in customer service and benefits verification, starting at a hospital lab and advancing through multiple roles in the pharmaceutical industry. Christina holds a Medical Assistant Certificate from Bryman College and a high school diploma from St. John's Ursuline High School.
This person is not in any offices
Pulmonx
2 followers
Pulmonx has developed the Zephyr Endobronchial Valve, a minimally invasive treatment for COPD/emphysema. The one-time procedure is done by bronchoscopy and requires no cutting or incisions. During the procedure, on average 4 tiny valves are placed in the airways to block off the diseased parts of the lung which allows trapped air to escape until the lobe is reduced. Reducing hyperinflation allows the healthier parts of the lungs to expand and take in more air. This results in patients being able to breathe easier and have less shortness of breath.1